Skip to main content

Table 4 Pharmacological Therapy

From: Lowered blood pressure targets identify new, uncontrolled hypertensive cases: patient characteristics and implications for services in Thailand

  Controlled Blood Pressure (N = 64) Post-Guidelines Uncontrolled Blood Pressure (N = 130) Pre-Guidelines Uncontrolled Blood Pressure (N = 54) P value
Years diagnosed with hypertension (year), Mean (SD) 8.1 (3.68) 8.5 (4.99) 7.3 (4.93) 0.320
Years taking anti-hypertensive drugs (year), Mean (SD) 8 (3.78) 8.4 (4.97) 7.3 (4.93) 0.325
Class of current medications taken per day, Mean (SD) 3.3 (1.62) 3.0 (1.60) 2.7 (1.38) 0.166
Types of anti-hypertensive drugs taken per day,
 Mean (SD) 1.4 (0.64) 1.4 (0.58) 1.4 (0.56) 0.775
 Median (IQR) 1 (1–2) 1 (1–2) 1 (1–2) 0.861*
Number of times taking anti-hypertensive drugs,
 Mean (SD) 1.8 (0.46) 1.7 (0.52) 1.7 (0.48) 0.422
 Median (IQR) 2 (2–2) 2 (1–2) 2 (1–2) 0.414*
Types of current anti-hypertensive drug
 • Calcium channel blockers, n(col %) 36 (56.25) 74 (56.92) 33 (61.11) 0.842
 • ACEIs, n(col. %) 11 (17.19) 10 (7.69) 5 (9.26) 0.121
 • ARBs, n(col %) 26 (40.63) 70 (53.85) 25 (46.30) 0.205
 • Thiazide type, n(col %) 3 (4.69) 7 (5.38) 4 (7.41) 0.802
 • Beta blockers, n(col %) 7 (10.94) 13 (10.00) 2 (3.70) 0.312
 • Other, n(col %) 2 (3.13) 0 1 (1.85) 0.514
Combined drugs use, n(col. %) 9 (14.06) 13 (10.00) 6 (11.11) 0.702
Experience of side effects from anti-hypertensive drugs, n(col %) 6 (9.38) 11 (8.46) 8 (14.81) 0.418
High medication adherence, n(col %) 32 (50.00) 42 (32.31) 14 (25.93) 0.013
  1. *Kruskal-Wallis rank test